SIA
TNDM icon

Sit Investment Associates’s Tandem Diabetes Care TNDM Stock Holding History

Sit Investment Associates’s Portfolio TNDM Stock Details TNDM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q4 		– Sell
-11,350
Closed -$869K – 517
2016
Q3 		$869K Hold
11,350
– – 0.02% 319
2016
Q2 		$856K Hold
11,350
– – 0.02% 322
2016
Q1 		$989K Hold
11,350
– – 0.02% 317
2015
Q4 		$1.34M Buy
11,350
+1,605
+16% +$159K 0.03% 291
2015
Q3 		$859K Hold
9,745
– – 0.02% 329
2015
Q2 		$1.06M Hold
9,745
– – 0.02% 306
2015
Q1 		$1.23M Buy
+9,745
New +$1.27M 0.02% 286

Other funds holding TNDM

TGHSA
TPG Group Holdings (SBS) Advisors Fort Worth, Texas $10.1B AUM 22.58% 1-Year Est. Return
WA
Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return
FCM
Frontier Capital Management Boston, Massachusetts $9.73B AUM 55.65% 1-Year Est. Return
DCM
DAFNA Capital Management Los Angeles, California $440M AUM 109.12% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
RSCM
Rock Springs Capital Management Baltimore, Maryland $1.7B AUM 93.03% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
GIP
Granite Investment Partners El Segundo, California $1.63B AUM 38.09% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

Sit Investment Associates's TNDM Position: Q4 2016 in Review

Sit Investment Associates sold out of Tandem Diabetes Care (TNDM) in Q4 2016, closing a stake of 11,350 shares — an estimated $869K sold.

Sit Investment Associates first reported a position in TNDM in Q1 2015 and held it in 7 quarters. The position peaked at $1.34M in Q4 2015. 75 funds tracked by Wall St. Rank hold TNDM as of Q4 2016.

  • Sit Investment Associates reported no remaining Tandem Diabetes Care position as of Q4 2016 after selling out during the quarter.
  • Sit Investment Associates sold 11,350 Tandem Diabetes Care shares in Q4 2016, an estimated $869K.
  • Sit Investment Associates first reported a position in Tandem Diabetes Care in Q1 2015 and held it in 7 quarters.
  • Sit Investment Associates's Tandem Diabetes Care position peaked at $1.34M in Q4 2015.
  • 75 funds tracked by Wall St. Rank held Tandem Diabetes Care as of Q4 2016.

Based on Sit Investment Associates's 13F filing for Q4 2016, filed 19 Jan 2017.